EP0477833A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Composition for therapeutic and/or cosmetic use for treatment of circulatory diseases and for aesthetic medicine treatments
Assignee: Individual
•
Filing: 1991-09-24
•
Granted: —
•
Expires: 2011-09-24
Abstract
Abstract The combination in a composition for topical use of hydrogenated lecithins, hyaluronic acid and elastin, and possibly diachysis factor, is useful in the treatment of pathologies such as varicose veins, phlebitis, oedemas and obstructed veins as well as in applications of aesthetical medicine.
Inventors
- 👤 Rosa Dr. Sternberg Ruiu
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 11:20
CPC Classifications
A; A61; A61Q; A61Q19/00; A61Q19/06; A61K; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K38/00; A61K38/16; A61K38/17; A61K38/39; A61K8/00; A61K8/18; A61K8/30; A61K8/55; A61K8/553; A61K8/64; A61K8/72; A61K8/73; A61K8/735
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
39 words
Composition for therapeutic and/or cosmetic use, characterized in that it includes in combination as active ingredients hydroge ated lecithins, hyaluronic acid as well as elastin, together with the usual excipients, vehicles and solubilizing agents for liquid or fluid composition.
Claim 2
Dependent Claim
39 words
Composition for therapeutic and/or cosmetic use, characterized in that it includes in combination as active ingredients hydroge ated lecithins, hyaluronic acid as well as elastin, together with the usual excipients, vehicles and solubilizing agents for liquid or fluid composition.
Claim 3
Dependent Claim
20 words
Composition for therapeutic and/or cosmetic use, according to claim 1, characterized in that it includes in adddition the diachysis factor.
Claim 4
Dependent Claim
21 words
Composition for therapeutic and/or cosmetic use, according to claim 1, characterized in the following percentages by weight of said active ingredients:
Claim 5
Dependent Claim
30 words
Composition for therapeutic and/or cosmetic use, according to claim 2, characterized in that said diachysis factor is present in a percentage by weight included between 60 and 70 per cent.
Claim 6
Dependent Claim
14 words
Therapeutic and/or cosmetic composition, according to the preceding claims, characterized by the following formulation.
Claim 7
Dependent Claim
43 words
Composition, according to the preceding claims, for the therapy of varicose veins, phlebitis, oedema, sores induced from varicose ulcers, obstructed veins owing to a sclerozating therapy as well as for the restoration of circulation and for the normalization of walls of blood vessels.
Claim 8
Dependent Claim
24 words
Composition, according to the preceding claims, for the treatment of telangiectasia, acne, capillaritis of nose, limbs and face, cellulitis and states of tissue relaxation.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.